These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Local lymphoid response as an index of tumor immunity. Fisher ER; Fisher B Arch Pathol; 1972 Aug; 94(2):137-46. PubMed ID: 5046799 [No Abstract] [Full Text] [Related]
27. [Studies on the influence of the short-time narcosis during bronchoscopy on the cellular immunity (author's transl)]. Zochert J; Thomas U Z Erkr Atmungsorgane; 1980 Mar; 154(3):323-6. PubMed ID: 7415318 [TBL] [Abstract][Full Text] [Related]
28. Effects on tumor growth in vivo by manipulation of the tumor immune response. Sjögren HO Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816 [No Abstract] [Full Text] [Related]
30. In vitro methods for the assessment of cell-mediated tumor immunity. Nordin AA Natl Cancer Inst Monogr; 1972 Dec; 35():21-6. PubMed ID: 4572826 [No Abstract] [Full Text] [Related]
31. [Cell-mediated immunity studied by skin tests in patients receiving intensive care. Prognostic value of repeated tests. Study of some factors predisposing towards anergy (author's transl)]. Tasseau F; Gaucher L; Nicolas F Sem Hop; 1982 Apr; 58(13):781-4. PubMed ID: 6283652 [TBL] [Abstract][Full Text] [Related]
32. A guinea pig model for tumor immunology. A summary. Rapp HJ Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812 [No Abstract] [Full Text] [Related]
34. [Immunological diagnosis of malignant diseases outside the lymphoreticular system]. Wiig JN Tidsskr Nor Laegeforen; 1978 Sep; 98(25):1197-1200. PubMed ID: 358487 [No Abstract] [Full Text] [Related]
35. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
36. [Cell-mediated immunity in patients with non-lymphoid solid tumours. Correlation with tumour stage, response to therapy and survival (author's transl)]. Simo-Camps E; Anguera A; Vich JM; Vidal-Ribas A; Sala A; Sarrias R; Gumma J; Gri E; Puigdollers JM Sangre (Barc); 1975; 20(2):177-83. PubMed ID: 1145396 [No Abstract] [Full Text] [Related]
38. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status). Libánský J; Sedlácková M; Pinosová I Neoplasma; 1973; 20(1):61-7. PubMed ID: 4573872 [No Abstract] [Full Text] [Related]
39. Immunological reactivity in children with Wilms' tumor. Kowalczyk D; Szymik S; Grochowski J; Małek T; Zembala M Neoplasma; 1986; 33(4):509-18. PubMed ID: 3020456 [TBL] [Abstract][Full Text] [Related]
40. Immunologic defects in lung cancer patients. Holmes EC; Golub SH J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]